In a wide-ranging probe into the health impacts from four illicit drugs, a team led by Louisa Degenhardt at Australia's University of New South Wales also found that two-thirds of addicts are men, with the biggest problems emerging in males aged 20 to 29.
More than 55 per cent of drug-related deaths in 2010 were caused by opioids, the category which is dominated by heroin, according to their probe.
Adding to the dependence risk from heroin is the peril from injecting drug use, for shared syringes help spread HIV and hepatitis.
Like cocaine, it was a smaller source of death and disease compared to heroin and amphetamines, the investigation found.
As for drug addiction, the paper found that 17.2 million people were dependent on amphetamines in 2010, compared to 15.5 million for opioids and 13 million for cannabis.
A regional breakdown of the figures found that rich economies such as the United States, Britain and Australia had 20 times the rate of death and disease compared with the least affected countries. Among developing economies, South Africa stood out as having exceptionally high rates.
"Our results clearly show that illicit drug use is an important contributor to the global disease burden," said Degenhardt.
"Although we have fewer means of responding to some causes of burden, such as cocaine and amphetamine dependence, well-evaluated and effective interventions can substantially reduce two major causes of burden," she said, pointing to addiction to opioids and injecting drug use.
But, added Degenhardt, "the challenge will be to deliver these efficiently and on a scale needed to have an effect on a population level."
Overall, illicit drug dependence amounted in 2010 to just under one per cent of the total global burden of death and illness.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
